HDAC Inhibitor, Mammalian, BioAssay(TM) Drug Screening Kit

Inhibition of histone deacetylase (HDAC) has been implicated to modulate transcription and to induce apoptosis or differentiation in cancer cells. However, screening of compounds for HDAC inhibition has been difficult due to the lack of convenient tools for analyzing HDAC activity. The new HDAC Inhibitor Drug Screening Kit provides a fast, fluorescence-based method that eliminates radioactivity, extractions, or chromatography, as used in traditional assays. The new procedure requires only two easy steps, both performed on the same microtiter plate. First, your inhibitor candidates are mixed with HeLa Nuclear Extract and HDAC fluorometric substrate, which comprises an acetylated lysine side chain. Deacetylation of the substrate sensitizes the substrate, so that, in the second step, treatment with the Lysine Developer produces a fluorophore. The fluorophore can be easily analyzed using a fluorescence plate reader or a fluorometer. The assay is well suited for high throughput screening applications.\n\nSample Type:\nCell and Tissue lysates, culture media, urine, plasma and serum, as well as many other biological fluids.\n\nIntended Use:\nScreening of compounds for HDAC inhibition by analyzing HDAC activity.\n\nSpecificity:\nMammalian\n\nKit Componants:\nHDAC substrate (4mM), 1x500ul/ml\n10X HDAC assay buffer, 1x1ml\nLysine Developer, 1x1ml\nHDAC Inhibitor (1mM), 1x10ul\nHeLa nuclear extract, 1x200ul\n\nStorage and Stability:\nStore liquid at -20 degrees C. Stable for 6 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts